Interlaboratory agreement in the monitoring of unfractionated heparin using the anti-factor Xa-correlated activated partial thromboplastin time: reply to a rebuttal

被引：0
|
作者：
Cuker, A. [1 ]
Cines, D. B. [1 ,2 ]
Pollak, E. S. [2 ,3 ]
机构：
[1] Univ Penn, Dept Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[3] Childrens Hosp Philadelphia, Dept Pathol, Philadelphia, PA 19104 USA
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2009年 / 7卷 / 12期
关键词：
THERAPEUTIC RANGE; REAGENTS;
D O I：
10.1111/j.1538-7836.2009.03625.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2158 / 2159
页数：3
相关论文
共 50 条
  • [1] Interlaboratory agreement in the monitoring of unfractionated heparin using the anti-factor Xa-correlated activated partial thromboplastin time: a rebuttal
    Kitchen, S.
    Preston, F. E.
    Jennings, I.
    Kitchen, D. P.
    Woods, T. A. L.
    Walker, I.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (12) : 2157 - 2158
  • [2] Interlaboratory agreement in the monitoring of unfractionated heparin using the anti-factor Xa-correlated activated partial thromboplastin time
    Cuker, A.
    Ptashkin, B.
    Konkle, B. A.
    Pipe, S. W.
    Whinna, H. C.
    Zheng, X. L.
    Cines, D. B.
    Pollak, E. S.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (01) : 80 - 86
  • [3] Interlaboratory Precision in the Monitoring of Unfractionated Heparin Using the Anti-Factor Xa-Correlated Activated Partial Thromboplastin Time
    Cuker, Adam
    Ptashkin, Beverly
    Konkle, Barbara A.
    Pipe, Steven W.
    Whinna, Herbert C.
    Zheng, X. Long
    Cines, Douglas B.
    Pollak, Eleanor
    [J]. BLOOD, 2008, 112 (11) : 166 - 166
  • [4] Lack of Inter-Laboratory Agreement in the Monitoring of Unfractionated Heparin Using the Anti-Factor Xa Activity and the Anti-Factor Xa-Correlated Activated Partial Thromboplastin Time
    Toulon, Pierre
    Smahi, Motalib
    De Pooter, Neila
    Zereg, Elamine
    [J]. BLOOD, 2017, 130
  • [5] Comparing Anti-Factor Xa and Activated Partial Thromboplastin Levels for Monitoring Unfractionated Heparin
    Wahking, Rebekah A.
    Hargreaves, Rachel H.
    Lockwood, Sean M.
    Haskell, Sabrina K.
    Davis, Kelly W.
    [J]. ANNALS OF PHARMACOTHERAPY, 2019, 53 (08) : 801 - 805
  • [6] Comparing anti-factor Xa and activated partial thromboplastin levels for monitoring unfractionated heparin.
    Wahking, Rebekah A.
    Hargreaves, Rachel H.
    Lockwood, Sean M.
    Haskell, Sabrina K.
    Davis, Kelly
    [J]. PHARMACOTHERAPY, 2018, 38 (07): : E54 - E54
  • [7] ANTI-FACTOR XA VERSUS ACTIVATED PARTIAL THROMBOPLASTIN TIME FOR HEPARIN INFUSION MONITORING
    Jung, Sul
    Choi, Austin
    Lepore, Mark
    [J]. CRITICAL CARE MEDICINE, 2020, 48
  • [8] Activated Partial Thromboplastin Time versus Anti-Factor Xa Levels for Monitoring Unfractionated Heparin Therapy in Children: An Institutional Experience
    Woods, Gary M.
    Stanek, Joseph
    Harrison, Sheilah
    Texter, Karen
    Kerlin, Bryce A.
    Dunn, Amy L.
    Kumar, Riten
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2017, 39 (07) : 576 - +
  • [9] Clinical outcomes with unfractionated heparin monitored by anti-factor Xa vs. activated partial Thromboplastin time
    Coons, James C.
    Iasella, Carlo J.
    Thornberg, Megan
    Fitzmaurice, Mary Grace
    Goehring, Kimberly
    Jablonski, Lindsay
    Leader, Dominic
    Meyer, Abby
    Seo, Hangil
    Benedict, Neal J.
    Smith, Roy E.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (09) : 1015 - 1019
  • [10] Performance of Anti-Factor Xa Versus Activated Partial Thromboplastin Time for Heparin Monitoring Using Multiple Nomograms
    Whitman-Purves, Emily
    Coons, James C.
    Miller, Taylor
    DiNella, Jeannine V.
    Althouse, Andrew
    Schmidhofer, Mark
    Smith, Roy E.
    [J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2018, 24 (02) : 310 - 316
12345